{"name":"Marianne Goodman","slug":"marianne-goodman","ticker":"","exchange":"","domain":"","description":"Marianne Goodman is a biopharmaceutical company focused on the development of innovative treatments for sleep disorders. The company's lead candidate, Suvorexant, a dual orexin receptor antagonist, is currently in Phase 2 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNOTdoMDJQMXA2cTRhUFlGWi1aT3FYVnRwTHptMlpIOVdiWWJhY0RKRm9aRWVKVDc5MmN5Xzc1eUxiSm10amtwMlA0TXJlWlU0S3ZFb0w3NTVlakNrYVNDZElfQTlXZEVUUllTZ0x5VldreFljR1dRbnl5Y3dtd3FRZlotZ1doWFlPdmpBSERSOFRTRE5zdkhOaHhiSzVOOHR4dkI0?oc=5","date":"2025-11-06","type":"pipeline","source":"The New York Times","summary":"Who’s Selling the $10 Million Gold Toilet? Signs Point to the Mets’ Owner. - The New York Times","headline":"Who’s Selling the $10 Million Gold Toilet? Signs Point to the Mets’ Owner.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE5iM2VieHgwdjV5dy1sS24wMGFUR0JLOVdtQTBqdUQxQzRaNk5PNHJKWVJiYjZpWXExTE04UUlSWkQ4N0t2eG92U3JDT01VSThOcTVjcUdic19hZU1WUVV4SWpmdw?oc=5","date":"2023-09-24","type":"pipeline","source":"Artforum","summary":"Nan Goldin - Artforum","headline":"Nan Goldin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNWEhoZHdlN29xZHhrMW1TWHdzdWNTUFNVcWhqcVVOSERmRmY5SmY3eFVWTEl2VmlXc2FsNWNzU09URkFoWjBGTmhJVmZmR1p6bzlsczB2M1FwakZLYVB6Z1YtaTY2UzBTdDFmR3N6Wi1kTGY5SWNDbHVFNTc3OVZhYkxSbmhSWjZWTWtoSWVzVWhEOG96SXNuZkdn?oc=5","date":"2023-03-30","type":"pipeline","source":"The New York Times","summary":"Nan Goldin is Second Major Artist to Exit Marian Goodman Gallery (Published 2023) - The New York Times","headline":"Nan Goldin is Second Major Artist to Exit Marian Goodman Gallery (Published 2023)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5fbU0tT3EwbHFFbkZBU19FTkVIQmJHZ1hTcmlPRDE4aGpyZXh4dlMzVU1sNFhzbm8zeThpUjlfeXV6Y0Jld3Npdmd3Z2lMTDVFVDVtVVhoRTJ5Q0Ewa0RfUG42d1ExZ0J6QkHSAXJBVV95cUxNMXlDZ3JVT0pjME94RHFOVzRsUDlNbGc1M2Y1WVJVbU9pSGV3LWE3ZnIzQTlBQjlvYmxXZHFsNEZSYk1qZEZNdUE4REJwM3hHU1V0X0NhMkMxZlYwTWlWOGZtZ0tDRTNGM2c5czZhak9ja1E?oc=5","date":"2023-03-29","type":"deal","source":"Artnet News","summary":"Nan Goldin, the U.S. Artist Whose Salient Activism Took Down the Sacklers, Has Ditched Dealer Marian Goodman to Work With Gagosian - Artnet News","headline":"Nan Goldin, the U.S. Artist Whose Salient Activism Took Down the Sacklers, Has Ditched Dealer Marian Goodman to Work Wit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOcVBXMDZpMFRQcTlHaTJzTndWZ2xLRWlrN3U4bU5CVFhQbVV4SG4yUXZnbUdzSTBidExGRXMtNEExQXE5ZW13UVZzZ21KVWF1dG1MSDlKcjNlS1c3QnM1R3VqalV3SW5Ibmg2M3EwZ0NpZTRfeDRUbF85OWhtWHgzY0FnREQzQ0Q2SHB4dzNqNnk2SDBZVXNSQlBTSmExQU1KcTc3VVZsS2JNaFNwLVdLbHlyNXNCZGM?oc=5","date":"2023-03-29","type":"pipeline","source":"The Art Newspaper","summary":"Nan Goldin joins Gagosian, leaving Marian Goodman gallery after five years - The Art Newspaper","headline":"Nan Goldin joins Gagosian, leaving Marian Goodman gallery after five years","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBPbnJQZDVINEVfNUt0NHYyZ1h2REJUU09RQ0xuNEQxMXJHNGZSTWUyWjF3eWZGX0VaeUYzN3RHc0pMUmVRQkxBZmRLLTJhNFN0X1AzX2tleHBFczZSelJR?oc=5","date":"2022-07-13","type":"pipeline","source":"Nature","summary":"Development of a screening algorithm for borderline personality disorder using electronic health records - Nature","headline":"Development of a screening algorithm for borderline personality disorder using electronic health records","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTFBxQ2xJTFdZOXVtajM1MkhJZ2YwNGpTejFLaDFMaW1KZWhyN2ItVXQyM2pQNDJxX2p5amVJVjRtcEJTeGtpY2dMQ3hoeTRrOXY5YUM2VXBlMzU4d3hxZGpQTXNkdHZxWWFBUUdaellEcXV3QQ?oc=5","date":"2021-05-17","type":"pipeline","source":"Hyperallergic","summary":"The Thrill and Intimacy of Nan Goldin’s Gaze - Hyperallergic","headline":"The Thrill and Intimacy of Nan Goldin’s Gaze","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQZHdmZS1IZGg1TWpYSm5DWTEteFNmUnc5M25BR1BwSHV4UDZJZE5NVTZOM1pwOE5id05fT2tHa2VXWmJtbktrNldxS3RPUVdFU0ZZWjI3dHNlaGFPdDdMRmVXbVVrb1JRT0ZtbEpUMXBMcWh3NGNpTko0UVN2QW1tS3NPZ00zUC1feC1kdU84aw?oc=5","date":"2021-04-27","type":"pipeline","source":"The Eye of Photography","summary":"Marian Goodman Gallery : Nan Goldin : Memory Lost - The Eye of Photography","headline":"Marian Goodman Gallery : Nan Goldin : Memory Lost","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFBhUEozbFZjVnNYcF9FUllWTlBTekl1M1RXNE9hSVkzNmFxaG5Va3ptb0wtV2xaMHcwRHZ1MlFuNFZYMG51NlZnRWMwXzlTREpKbUszY01yT185SlJOc2FscHRWRzBzUGFpYzdkeDBKMklzUWVuU2hmWE1Wak8?oc=5","date":"2019-11-14","type":"pipeline","source":"W Magazine","summary":"A First Look at Nan Goldin's New Work, Which Grapples With Addiction - W Magazine","headline":"A First Look at Nan Goldin's New Work, Which Grapples With Addiction","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxNQV93Rlc3UWFQcDYySWRaUTZWNVZjWjZHQ1djN2NQaTdSQ0VweVQ4MEFQTWVGWmNwaFF0Y1hlTVZfMVVKaUFmM1RtWGYzdXo3a3RFQ1NGbC16akFUbVphcjl0WHhicVhTeVBWd3NMeU9QdkdaSTVva3lTenBWTnpNd18xSUoydno4S2Zxc1BVUXRhdDdkeDRCQkhacnNPOEZZMnhnUGtPMGdqUGVmYUd3Z3c4THVjMzBrUGFwSTZiNW1TbHhkbkZvSUJ1cnNEV19F?oc=5","date":"2019-11-14","type":"pipeline","source":"The Guardian","summary":"Nan Goldin review – Gut-wrenching, brilliant and beautiful. I cannot turn away - The Guardian","headline":"Nan Goldin review – Gut-wrenching, brilliant and beautiful. I cannot turn away","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTFBaMUlvcm8zTHB2RnlDd1Q1TUZ0NXF0NTNnSzl4S1RRSjhDTm94TmR0TzZEd1l5UEtxcDQyczNXcnJhOXdCTENtRDBUNUlLQlp6V3Nib0o5cTBVRnJhZWZ0R3VxVnF3UHBaU1V0dU9ycS0?oc=5","date":"2019-11-14","type":"pipeline","source":"Sleek Magazine","summary":"The many lives of Nan Goldin - Sleek Magazine","headline":"The many lives of Nan Goldin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE1sRnd6SHlhM3F0RXVnXzNBMmZ4YkJKTHF0c18yUnR6OVdBTWNKa05fbEtDcEJYMVRoYmJDcmFHbjJza245OU1sTVkyTTRBYXlKcWt2Yk1rMGduZmtfVEhXWjRLQm9yTFVTWldRQkJmaHdwNnB1MXlaR1BFV1oySTA?oc=5","date":"2014-08-05","type":"pipeline","source":"WSJ","summary":"Marian Goodman's New London Gallery - WSJ","headline":"Marian Goodman's New London Gallery","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}